ARCHIVES

Agency Expands Gleevec Label To Include Rare GIST Subset

This article is from The Cancer Letter archive.

Vol. 35 No. 2 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Approves New Toxicology Protocol; Drug Program Under Fire; DCT Board Approves Cutbacks, Contract Concepts

October 9, 1981

In Brief: NCHSR Says Autologous Marrow Transplant Is A “Reasonable Therapeutic Alternative”

August 11, 1989

Cooperative Group Massacre Hurt Some Of Best CCOPs Which May Go Unfunded

March 27, 1987

Budget Difficulties Aside, Centers Important To NCI, Broder Asserts; Warns Against Sabotage.

July 12, 1991

ONS Urges Congress To Back Anti-Tobacco Measures.

July 20, 2001

NCI Expected of Fund Cancer Education Grants In Fiscal 1986; Final Fate to Be Decided This Week

March 7, 1986